Skip to main content
. 2020 Apr 6;192(14):E351–E360. doi: 10.1503/cmaj.191283

Figure 2:

Figure 2:

Subgroup analyses for the outcome of AKI from sodium–glucose cotransporter-2 (SGLT2) inhibitor use. Note: ACE = angiotensin-converting–enzyme inhibitor, AKI = acute kidney injury, ARB = angiotensin receptor blocker, CI = confidence interval, DPP4 = dipeptidyl peptidase-4, eGFR = estimated glomerular filtration rate, NA = not applicable. *Types of diuretics included loop, potassium sparing and thiazide.